As of 2026-05-21, the Fair Value of Microbot Medical Inc (MBOT) is -0.98 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.74 USD, the upside of Microbot Medical Inc is -156.23%.
With the market price of 1.74 USD and our fair value calculation, Microbot Medical Inc (MBOT) is not a good investment. Investing in MBOT stocks now will result in a potential loss of 156.23%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -11.31 | -13.17 | -10.74 | -11.44 | -13.14 | -11.96 |
| YoY growth | -23.34% | -16.45% | 18.45% | -6.55% | -14.85% | -8.54% |
| Market Cap (mil) | 116.86 |
| P/E | |
| Forward P/E |
| EPS | -0.20 |
| Avg earnings growth rate | -8.54% |
| TTM earnings | -13.14 |